GUARDIAN  |  Science

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 糖尿病药物或可防止焦虑和抑郁加重，研究发现

Semaglutide, the active ingredient in Ozempic for diabetes and Wegovy for weight loss, as well as liraglutide (Saxenda) were associated with a lower risk of worsening mental illness in those with anxiety and depression.

Semaglutide, the active ingredient in Ozempic for diabetes and Wegovy for weight loss, as well as liraglutide (Saxenda) were associated with a lower risk of worsening mental illness in those with anxiety and depression.

2026-03-18  662词  中等
字体
GLP-1 receptor agonists such as semaglutide are commonly prescribed for diabetes and obesity. While studies have found other health benefits beyond weight loss and better blood sugar levels, the medications’ effects on mental health have been unclear.

请登录后继续阅读完整文章

还没有账号？立即注册

成为会员后您将享受无限制的阅读体验，并可使用更多功能，了解更多

免责声明：本文来自网络公开资料，仅供学习交流，其观点和倾向不代表本站立场。